Turn Therapeutics (TTRX) Share-based Compensation (2024 - 2026)
Turn Therapeutics' (TTRX) quarterly Share-based Compensation came in at $1.2 million in Q1 2026, up 1466.64% year-on-year from $76597.0 in Q1 2025, and up 368.06% quarter-over-quarter from $256380.0 in Q4 2025.
Turn Therapeutics (TTRX) Share-based Compensation (2024 - 2026) Analysis & Trends
Turn Therapeutics' Share-based Compensation history runs 3 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 1466.64% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, up 296.79% from the prior year.
- Share-based Compensation improved to $1.2 million in Q1 2026 per TTRX's latest filing, from $256380.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.2 million in Q1 2026 and bottomed at $37813.0 in Q4 2024.
- The 3-year median for Share-based Compensation is $256380.0 (2025), against an average of $375228.0.
- Across the five-year window, Share-based Compensation jumped 578.02% in 2025 and jumped 1466.64% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $37813.0 in 2024, then soared by 578.02% to $256380.0 in 2025, then jumped by 368.06% to $1.2 million in 2026.
- Per Business Quant, the three latest TTRX Share-based Compensation figures stand at $1.2 million (Q1 2026), $256380.0 (Q4 2025), and $305350.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Turn Therapeutics | 282.39 Mn | 282.39 Mn | - | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 256,380.00 |
| Dec 31, 2025 | 256,380.00 |
| Sep 30, 2025 | 305,350.00 |
| Sep 30, 2025 | 305,350.00 |
| Mar 31, 2025 | 76,597.00 |
| Mar 31, 2025 | 76,597.00 |
| Dec 31, 2024 | 37,813.00 |
| Dec 31, 2024 | 37,813.00 |